Piperlongumine

別名：PPLGM, Piplartine

製品コード：S7551 純度：99.33%

Piperlongumine (PPLGM, Piplartine), a natural alkaloid from Piper longum L., increases the level of reactive oxygen species (ROS) and selectively kills cancer cells. It is a direct TrxR1 inhibitor with suppressive activity against gastric cancer and a novel inhibitor of CRM1; also an inhibitor of PI3K/Akt/mTOR in human breast cancer cells.

CAS No. 20069-09-4

サイズ	価格(税別)	在庫状況
10mM (1mL in DMSO)	JPY 29500	国内在庫あり
10mg	JPY 22000	国内在庫あり
50mg	JPY 53500	国内在庫あり
200mg	JPY 142000	国内在庫あり
1g	JPY 295500	国内在庫なし(納期7~10日)

代表番号: 045-509-1970\|電子メール：[email protected] よく尋ねられる質問

文献中Selleckの製品使用例（25）

カスタマーフィードバック2例

製品安全説明書

現在のバッチを見る：純度： 99.33%

99.33

Piperlongumine関連製品

関連製品	MitoQ (Mitoquinone) mesylate H2DCFDA (DCFH-DA) Neohesperidin Carnosic acid Gallic acid (20R)Ginsenoside Rg3 Pyrogallol Idebenone Asiaticoside Sarsasapogenin Troxerutin	もっと見る
関連化合物ライブラリー	Kinase Inhibitor Library FDA-approved Drug Library Natural Product Library Bioactive Compound Library-I Bioactive Compound Library-Ⅱ	もっと見る

ROS阻害剤の選択性比較

Cell Data

Cell Lines	Assay Type	Concentration	Incubation Time	活性情報	PMID
A549	Function assay	10 uM	4 hrs	Reduction in total GSH level in human A549 cells at 10 uM after 4 hrs by luminescence assay	25826398
A549	Function assay	10 uM	4 hrs	Reduction in reduced GSH level in human A549 cells at 10 uM after 4 hrs by luminescence assay	25826398
U937	Apoptosis assay	2 uM	24 hrs	Induction of apoptosis in p53 null human U937 cells assessed as caspase 3 cleavage at 2 uM after 24 hrs in presence of SAHA by Western blot analysis	27505848
U937	Apoptosis assay	2 uM	24 hrs	Induction of apoptosis in p53 null human U937 cells assessed as PARP-1 cleavage at 2 uM after 24 hrs in presence of SAHA by Western blot analysis	27505848
U937	Cell death assay	1 to 4 uM	24 hrs	Induction of cell death in p53 null human U937 cells at 1 to 4 uM after 24 hrs by annexin V-FITC/PI staining based flow cytometry	27505848
U937	Cytotoxicity assay	0.5 to 5 uM	24 hrs	Cytotoxicity against p53 null human U937 cells assessed as decrease in cell viability at 0.5 to 5 uM after 24 hrs in presence of SAHA by MTT assay	27505848
U937	Function assay	2 uM	20 hrs	Induction of DNA damage in p53 null human U937 cells at 2 uM after 20 hrs in presence of SAHA by SYBR gold staining based alkaline comet assay	27505848
MCF7	Apoptosis assay	10 uM	48 hrs	Induction of apoptosis in human MCF7 cells assessed as downregulation of Bcl2 expression at 10 uM after 48 hrs by Western blot method	27689728
MCF7	Apoptosis assay	10 uM	72 hrs	Induction of apoptosis in human MCF7 cells assessed as downregulation of Mcl-1 expression at 10 uM after 72 hrs by Western blot method	27689728
MCF7	Function assay	20 uM	16 hrs	Disruption of microtubule network in human MCF7 cells at 20 uM after 16 hrs by immunofluorescence analysis	27689728
MCF7	Function assay	10 uM	16 hrs	Induction of microtubule depolymerization in human MCF7 cells at 10 uM after 16 hrs by immunofluorescence analysis	27689728
MCF7	Function assay	1 to 20 uM	48 hrs	Induction of reactive oxygen species generation in human MCF7 cells assessed as decrease in cell viability at 1 to 20 uM in presence of trolox after 48 hrs by alamarBlue assay	27689728
MCF7	Function assay	5 to 20 uM	4 hrs	Induction of tubulin depolymerization in human MCF7 cells at 5 to 20 uM after 4 hrs by Western blot method	27689728
Jurkat	Function assay	5 to 20 uM	4 hrs	Induction of tubulin depolymerization in human Jurkat cells at 5 to 20 uM after 4 hrs by Western blot method	27689728
HCT116	Function assay	10 uM	1 hr	Induction of reactive oxygen species generation in human HCT116 cells at 10 uM after 1 hr by DCFH-DA dye-based fluorescence microscopic analysis	28434764
HCT116	Cell cycle assay	1 to 5 uM	24 hrs	Cell cycle arrest in human HCT116 cells assessed as accumulation at S phase 1 to 5 uM after 24 hrs by propidium iodide staining based flow cytometric method	28434764
HCT116	Cell cycle assay	1 to 5 uM	24 hrs	Cell cycle arrest in human HCT116 cells assessed as accumulation at G0/G1 phase at 1 to 5 uM after 24 hrs by propidium iodide staining based flow cytometric method	28434764
HCT116	Cell cycle assay	1 to 5 uM	24 hrs	Cell cycle arrest in human HCT116 cells decrease in population at G0/G1 phase at 1 to 5 uM after 24 hrs by propidium iodide staining based flow cytometric method	28434764
HCT116	Antiproliferative assay	10 uM	72 hrs	Antiproliferative activity against human HCT116 cells at 10 uM after 72 hrs by MTT assay	28686911
A549	Antiproliferative assay	10 uM	72 hrs	Antiproliferative activity against human A549 cells at 10 uM after 72 hrs by MTT assay	28686911
K562	Antiproliferative assay	10 uM	72 hrs	Antiproliferative activity against human K562 cells at 10 uM after 72 hrs by MTT assay	28686911
HCT116	Antimigratory assay	50 nM	48 hrs	Antimigratory activity in human HCT116 cells assessed as inhibition of TGF-beta1-induced cell migration at 50 nM after 48 hrs by trans-well assay	29424539
HCT116	Function assay	10 uM	3 hrs	Induction of ROS accumulation in human HCT116 cells at 10 uM after 3 hrs by DCFH-DA staining-based fluorescence microscopic analysis	29424539
HCT116	Antiproliferative assay	8 uM	72 hrs	Antiproliferative activity against human HCT116 cells at 8 uM after 72 hrs by MTT assay	29424539
HCT116	Antiinvasive assay	50 nM	48 hrs	Antiinvasive activity in human HCT116 cells assessed as inhibition of TGF-beta1-induced cell invasion at 50 nM after 48 hrs by crystal violet staining-based assay	29424539
HCT116	Function assay	50 nM	1 hr	Inhibition of IL-1beta-mediated adhesion of human rhodamine 123-labeled HCT116 cells to HUVEC at 50 nM after 1 hr by fluoresence assay	29424539
HCT116	Function assay	50 nM	48 hrs	Inhibition of TGF-beta1-induced decrease in expression levels of E-cadherin protein in human HCT116 cells at 50 nM after 48 hrs by Western blot analysis	29424539
HCT116	Function assay	50 nM	48 hrs	Inhibition of TGF-beta1-induced increase in expression levels of vimentin protein in human HCT116 cells at 50 nM after 48 hrs by Western blot analysis	29424539
HCT116	Function assay	50 nM	48 hrs	Inhibition of TGF-beta1-induced increase in expression levels of MMP-9 protein in human HCT116 cells at 50 nM after 48 hrs by Western blot analysis	29424539
HCT116	Function assay	50 nM	48 hrs	Inhibition of TGF-beta1-induced increase in expression levels of snail protein in human HCT116 cells at 50 nM after 48 hrs by Western blot analysis	29424539
HCT116	Function assay	50 nM	48 hrs	Inhibition of TGF-beta1-induced increase in expression levels of twist protein in human HCT116 cells at 50 nM after 48 hrs by Western blot analysis	29424539
HCT116	Function assay	50 nM	48 hrs	Inhibition of TGF-beta1-induced AKT phosphorylation in human HCT116 cells at 50 nM after 48 hrs by Western blot analysis	29424539
HCT116	Function assay	50 nM	48 hrs	Inhibition of TGF-beta1-induced GSK-3beta phosphorylation in human HCT116 cells at 50 nM after 48 hrs by Western blot analysis	29424539
HCT116	Function assay	50 nM	48 hrs	Inhibition of TGF-beta1-regulated decrease in cytoplasmic beta-catenin in human HCT116 cells at 50 nM after 48 hrs by Western blot analysis	29424539
HCT116	Function assay	50 nM	48 hrs	Inhibition of TGF-beta1-regulated increase in nuclear beta-catenin in human HCT116 cells at 50 nM after 48 hrs by Western blot analysis	29424539
WI38	Function assay	5 uM	24 hrs	Induction of OXR1 degradation in ionizing radiation induced human WI38 senescent cells at 5 uM after 24 hrs by Western blot analysis	29925484
WI38	Function assay	up to 64 uM	1.5 hrs	Induction of ROS production in ionizing radiation induced human WI38 senescent cells up to 64 uM after 1.5 hrs by DHR123 dye based flow cytometry	29925484
RAW264.7	Function assay	10 uM	0.5 hrs	Inhibition of MAPK/NFkappaB in ICR mouse RAW264.7 cells assessed as reduction in LPS-induced TNFalpha production at 10 uM pretreated for 0.5 hrs followed by LPS challenge and measured after 24 hrs by ELISA relative to control	30780088
RAW264.7	Function assay	10 uM	0.5 hrs	Inhibition of MAPK/NFkappaB in ICR mouse RAW264.7 cells assessed as reduction in LPS-induced IL6 production at 10 uM pretreated for 0.5 hrs followed by LPS challenge and measured after 24 hrs by ELISA relative to control	30780088
HaCaT	Cytotoxicity assay		24 hrs	Cytotoxicity against human HaCaT cells assessed as reduction in cell viability after 24 hrs by MTT reduction assay, IC50=16μM	25305718
PANC1	Cytotoxicity assay		24 hrs	Cytotoxicity against human PANC1 cells assessed as reduction in cell viability after 24 hrs by MTT reduction assay, IC50=3.2μM	25305718
MRC5	Cytotoxicity assay		72 hrs	Cytotoxicity against human MRC5 cells after 72 hrs by MTT assay, IC50=35.04μM	24937186
WI38	Cytotoxicity assay		72 hrs	Cytotoxicity against human WI38 cells after 72 hrs by MTT assay, IC50=26.78μM	24937186
A549	Cytotoxicity assay		72 hrs	Cytotoxicity against human A549 cells after 72 hrs by MTT assay, IC50=22.85μM	24937186
MDA-MB-231	Cytotoxicity assay		72 hrs	Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTT assay, IC50=8.46μM	24937186
HCT116	Cytotoxicity assay		72 hrs	Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay, IC50=6.04μM	24937186
ZR75-30	Cytotoxicity assay		72 hrs	Cytotoxicity against human ZR75-30 cells after 72 hrs by MTT assay, IC50=5.86μM	24937186
MA9.3	Cytotoxicity assay		48 hrs	Cytotoxicity against human MA9.3 cells after 48 hrs by MTT assay, IC50=2μM	25464887
SK-MEL-2	Antiproliferative assay		72 hrs	Antiproliferative activity against human SK-MEL-2 cells after 72 hrs by MTT assay, EC50=4.39μM	25826398
HaCaT	Antiproliferative assay		72 hrs	Antiproliferative activity against human HaCaT cells after 72 hrs by MTT assay, EC50=4.46μM	25826398
A375	Antiproliferative assay		72 hrs	Antiproliferative activity against human A375 cells after 72 hrs by MTT assay, EC50=6.17μM	25826398
HCT116	Antiproliferative assay		72 hrs	Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay, EC50=11.5μM	25826398
A549	Antiproliferative assay		72 hrs	Antiproliferative activity against human A549 cells after 72 hrs by MTT assay, EC50=12.2μM	25826398
HFF1	Antiproliferative assay		72 hrs	Antiproliferative activity against HFF1 cells after 72 hrs by MTT assay, EC50=13.1μM	25826398
MCF10A	Antiproliferative assay		72 hrs	Antiproliferative activity against human MCF10A cells after 72 hrs by MTT assay, EC50=18.1μM	25826398
A549	Function assay		3 hrs	Induction of ROS production in human A549 cells after 3 hrs by DHE staining-based fluorescence assay	25826398
A549	Function assay		3 hrs	Induction of ROS production in human A549 cells after 3 hrs by APF staining-based fluorescence assay	25826398
HT1080	Cytotoxicity assay		72 hrs	Cytotoxicity against human HT1080 cells assessed as cell viability after 72 hrs by resazurin reduction assay, IC50=3.43μM	26599530
GBM10	Cytotoxicity assay		72 hrs	Cytotoxicity against human GBM10 cells assessed as cell viability after 72 hrs by resazurin reduction assay, IC50=3.81μM	26599530
SF188	Cytotoxicity assay		72 hrs	Cytotoxicity against human SF188 cells assessed as cell viability after 72 hrs by resazurin reduction assay, IC50=3.9μM	26599530
SKBR3	Cytotoxicity assay		72 hrs	Cytotoxicity against human SKBR3 cells assessed as cell viability after 72 hrs by resazurin reduction assay, IC50=4.04μM	26599530
T98G	Cytotoxicity assay		72 hrs	Cytotoxicity against human T98G cells assessed as cell viability after 72 hrs by resazurin reduction assay, IC50=4.92μM	26599530
HT-29	Cytotoxicity assay		72 hrs	Cytotoxicity against human HT-29 cells assessed as cell viability after 72 hrs by resazurin reduction assay, IC50=5.49μM	26599530
MCF7	Cytotoxicity assay		72 hrs	Cytotoxicity against human MCF7 cells assessed as cell viability after 72 hrs by resazurin reduction assay, IC50=6.14μM	26599530
A549	Cytotoxicity assay		72 hrs	Cytotoxicity against human A549 cells assessed as cell viability after 72 hrs by resazurin reduction assay, IC50=6.54μM	26599530
MV4-11	Antiproliferative assay		72 hrs	Antiproliferative activity against human MV4-11 cells after 72 hrs in presence of SAHA by MTT assay, IC50=0.2891μM	27505848
CMK	Antiproliferative assay		72 hrs	Antiproliferative activity against Ara-C resistant human CMK cells after 72 hrs in presence of SAHA by MTT assay, IC50=0.4218μM	27505848
CMY	Antiproliferative assay		72 hrs	Antiproliferative activity against human CMY cells after 72 hrs in presence of SAHA by MTT assay, IC50=0.4424μM	27505848
HL60	Antiproliferative assay		72 hrs	Antiproliferative activity against human HL60 cells after 72 hrs in presence of SAHA by MTT assay, IC50=0.5292μM	27505848
CMK	Antiproliferative assay		72 hrs	Antiproliferative activity against human CMK cells after 72 hrs in presence of SAHA by MTT assay, IC50=0.6127μM	27505848
U937	Antiproliferative assay		72 hrs	Antiproliferative activity against p53 null human U937 cells after 72 hrs in presence of SAHA by MTT assay, IC50=0.767μM	27505848
MOLM13	Antiproliferative assay		72 hrs	Antiproliferative activity against human MOLM13 cells harboring wild type p53/FLT3-ITD mutant after 72 hrs in presence of SAHA by MTT assay, IC50=0.9345μM	27505848
CMS	Antiproliferative assay		72 hrs	Antiproliferative activity against human CMS cells after 72 hrs in presence of SAHA by MTT assay, IC50=1.037μM	27505848
OCI-AML3	Antiproliferative assay		72 hrs	Antiproliferative activity against human OCI-AML3 cells after 72 hrs in presence of SAHA by MTT assay, IC50=1.109μM	27505848
HL60	Antiproliferative assay		72 hrs	Antiproliferative activity against Ara-C resistant human HL60 cells after 72 hrs in presence of SAHA by MTT assay, IC50=1.128μM	27505848
MV4-11	Antiproliferative assay		72 hrs	Antiproliferative activity against human MV4-11 cells after 72 hrs by MTT assay, IC50=1.439μM	27505848
CMY	Antiproliferative assay		72 hrs	Antiproliferative activity against human CMY cells after 72 hrs by MTT assay, IC50=1.62μM	27505848
HL60	Antiproliferative assay		72 hrs	Antiproliferative activity against human HL60 cells after 72 hrs by MTT assay, IC50=1.778μM	27505848
MOLM13	Antiproliferative assay		72 hrs	Antiproliferative activity against human MOLM13 cells harboring wild type p53/FLT3-ITD mutant after 72 hrs by MTT assay, IC50=1.838μM	27505848
OCI-AML3	Antiproliferative assay		72 hrs	Antiproliferative activity against human OCI-AML3 cells after 72 hrs by MTT assay, IC50=1.868μM	27505848
CMK	Antiproliferative assay		72 hrs	Antiproliferative activity against Ara-C resistant human CMK cells after 72 hrs by MTT assay, IC50=1.911μM	27505848
U937	Antiproliferative assay		72 hrs	Antiproliferative activity against p53 null human U937 cells after 72 hrs by MTT assay, IC50=2.174μM	27505848
HL60	Antiproliferative assay		72 hrs	Antiproliferative activity against Ara-C resistant human HL60 cells after 72 hrs by MTT assay, IC50=2.25μM	27505848
CMK	Antiproliferative assay		72 hrs	Antiproliferative activity against human CMK cells after 72 hrs by MTT assay, IC50=2.815μM	27505848
CMS	Antiproliferative assay		72 hrs	Antiproliferative activity against human CMS cells after 72 hrs by MTT assay, IC50=3.097μM	27505848
MCF7	Antiproliferative assay		48 hrs	Antiproliferative activity in human MCF7 cells assessed as cell viability after 48 hrs by alamarBlue assay, IC50=1.2μM	27689728
Jurkat	Antiproliferative assay		48 hrs	Antiproliferative activity in human Jurkat cells assessed as cell viability after 48 hrs by alamarBlue assay, IC50=1.4μM	27689728
Jurkat	Cytotoxicity assay		24 hrs	Cytotoxicity against human Jurkat cells after 24 hrs by MTT assay, IC50=5μM	27689728
MCF7	Cytotoxicity assay		24 hrs	Cytotoxicity against human MCF7 cells after 24 hrs by MTT assay, IC50=8μM	27689728
A549	Function assay		24 hrs	Inhibition of NF-kappaB in human A549 cells after 24 hrs by luciferase reporter gene assay, IC50=1.76μM	27810594
HepG2	Cytotoxicity assay		72 hrs	Cytotoxicity against human HepG2 cells assessed as growth inhibition after 72 hrs by MTT assay, IC50=8.9μM	28159415
HCT116	Cytotoxicity assay		72 hrs	Cytotoxicity against human HCT116 cells assessed as growth inhibition after 72 hrs by MTT assay, IC50=9.2μM	28159415
A549	Cytotoxicity assay		72 hrs	Cytotoxicity against human A549 cells assessed as growth inhibition after 72 hrs by MTT assay, IC50=10μM	28159415
MRC5	Cytotoxicity assay		72 hrs	Cytotoxicity against human MRC5 cells after 72 hrs by MTT assay, IC50=37μM	28159415
A549	Antiproliferative assay		72 hrs	Antiproliferative activity against human A549 cells after 72 hrs by MTT assay, IC50=6.84μM	28434764
Saos2	Antiproliferative assay		72 hrs	Antiproliferative activity against human Saos2 cells after 72 hrs by MTT assay, IC50=7.31μM	28434764
HCT116	Antiproliferative assay		72 hrs	Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay, IC50=7.34μM	28434764
U2OS	Antiproliferative assay		72 hrs	Antiproliferative activity against human U2OS cells after 72 hrs by MTT assay, IC50=9.49μM	28434764
MDA-MB-231	Antiproliferative assay		72 hrs	Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by MTT assay, IC50=10.6μM	28434764
SKHEP1	Antiproliferative assay		72 hrs	Antiproliferative activity against human SKHEP1 cells after 72 hrs by MTT assay, IC50=13.3μM	28434764
HT-29	Antiproliferative assay		72 hrs	Antiproliferative activity against human HT-29 cells after 72 hrs by MTT assay, IC50=2.65μM	28686911
HCT8	Antiproliferative assay		72 hrs	Antiproliferative activity against human HCT8 cells after 72 hrs by MTT assay, IC50=4.1μM	28686911
HCT116	Antiproliferative assay		72 hrs	Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay, IC50=8.13μM	28686911
CCD-841	Cytotoxicity assay		72 hrs	Cytotoxicity against human CCD-841 cells assessed as reduction in cell viability after 72 hrs by MTT assay, IC50=44.32μM	28686911
HT-29	Antiproliferative assay		72 hrs	Antiproliferative activity against human HT-29 cells after 72 hrs by MTT assay, IC50=2.65μM	29424539
HCT8	Antiproliferative assay		72 hrs	Antiproliferative activity against human HCT8 cells after 72 hrs by MTT assay, IC50=4.1μM	29424539
SW620	Antiproliferative assay		72 hrs	Antiproliferative activity against human SW620 cells after 72 hrs by MTT assay, IC50=4.62μM	29424539
K562	Antiproliferative assay		72 hrs	Antiproliferative activity against human K562 cells after 72 hrs by MTT assay, IC50=5.05μM	29424539
K562	Antiproliferative assay		72 hrs	Antiproliferative activity against human K562 cells after 72 hrs in presence of ligustrazine by MTT assay, IC50=5.09μM	29424539
HCT116	Antiproliferative assay		72 hrs	Antiproliferative activity against human HCT116 cells after 72 hrs by MTT assay, IC50=8.13μM	29424539
HCT116	Antiproliferative assay		72 hrs	Antiproliferative activity against human HCT116 cells after 72 hrs in presence of ligustrazine by MTT assay, IC50=8.17μM	29424539
A549	Antiproliferative assay		72 hrs	Antiproliferative activity against human A549 cells after 72 hrs in presence of ligustrazine by MTT assay, IC50=15.22μM	29424539
A549	Antiproliferative assay		72 hrs	Antiproliferative activity against human A549 cells after 72 hrs by MTT assay, IC50=15.28μM	29424539
U87MG	Antiproliferative assay		72 hrs	Antiproliferative activity against human U87MG cells after 72 hrs in presence of ligustrazine by MTT assay, IC50=16.15μM	29424539
U87MG	Antiproliferative assay		72 hrs	Antiproliferative activity against human U87MG cells after 72 hrs by MTT assay, IC50=17.34μM	29424539
CCD-841	Antiproliferative assay		72 hrs	Antiproliferative activity against human CCD-841 cells after 72 hrs by MTT assay, IC50=44.32μM	29424539
DU145	Function assay		24 hrs	Inhibition of STAT3 phosphorylation at Tyr705 residues in human DU145 cells after 24 hrs by Western blot analysis, IC50=7μM	29807795
DU145	Growth inhibition assay		48 hrs	Growth inhibition of human DU145 cells after 48 hrs by WST-1 assay, GI50=7.1μM	29807795
LNCAP	Growth inhibition assay		48 hrs	Growth inhibition of human LNCAP cells after 48 hrs by WST-1 assay, GI50=9.2μM	29807795
BHK21	Cytotoxicity assay		48 hrs	Cytotoxicity against BHK21 cells assessed as reduction in cell viability after 48 hrs by MTT assay, CC50=40.14μM	31009908
SH-SY5Y	Cytotoxicity assay		72 hrs	Cytotoxicity against human SH-SY5Y cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay, IC50=5.94μM	31400708
U87	Cytotoxicity assay		72 hrs	Cytotoxicity against human U87 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay, IC50=7.18μM	31400708
SH-SY5Y	Function assay		15 mins	Inhibition of TrxR in human SH-SY5Y cells using DTNB as substrate preincubated for 15 mins followed by substrate addition and measured for 20 mins by Ellman's method, IC50=45.88μM	31400708
RAW264.7	Antiinflammatory assay			Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced NO production, IC50=3μM	25453809
WI38	Function assay			Senolytic activity against ionizing radiation induced human WI38 senescent cells assessed as reduction in cell viability by propidium iodide staining based flow cytometry, EC50=8μM	29925484
WI38	Function assay			Senolytic activity against non-senescent human WI38 cells assessed as reduction in cell viability by propidium iodide staining based flow cytometry, EC50=20.3μM	29925484
他の多くの細胞株試験データをご覧になる場合はこちらをクリックして下さい

生物活性

製品説明

Targets

reactive oxygen species (ROS) ^[1]

TrxR1 ^[5]

CRM1 ^[6]

PI3K/Akt/mTOR ^[7]

In Vitro
In vitro	Piperlongumine is a known ROS inducer which could induce pancreatic cancer cell death in cell culture^[1] As a thromboxane A(2) receptor antagonist, Piperlongumine inhibits platelet aggregation. ^[2] Piperlongumine also promotes autophagy via inhibition of Akt/mTOR signalling and mediates cancer cell death. ^[3]
細胞実験	細胞株	MCF-7 and 786-O cells
	濃度	~10 μM
	反応時間	48 hours
	実験の流れ	MCF-7 and 786-O cells are incubated with various PL concentrations for 48h. Cell proliferation is analysed by CellTiter Blue assay. Effective doses (ED) are calculated using XLift, Microsoft Excel add-in.
実験結果図	Methods	Biomarkers	結果図	PMID
	Western blot	CDK2 / Cyclin E / Cyclin A Bax / Bcl-2 Survivin / p21 / p27 p-STAT3 / STAT3 / p-JAK2 / JAK2 / c-myc Hexokinase 1 / Hexokinase 2 p-AKT / AKT / p-S6 / S6		27634873
	Growth inhibition assay	Cell viability		25193861

In Vivo
In Vivo	Piperlongumine (50 mg/kg i.p.) causes in vivo growth inhibition of tumor cells without leading to major changes in the biochemical, hematological and histopathological parameters. ^[4]
動物実験	動物モデル	Mice transplanted with sarcoma 180 tumors
	投与量	~50 mg/kg
	投与経路	i.p.

参考
[1] Dhillon H, et al. Toxicol Rep. 2014, 1:309-318. [2] Iwashita M, et al. Eur J Pharmacol. 2007, 570(1-3), 38-42. [3] Ryu J, et al. Nat Prod Res. 2014, 28(22), 2040-2043. [4] Bezerra DP, et al. J Appl Toxicol. 2008, 28(5), 599-607. [5] Zou P, et al. Cancer Lett. 2016, 375(1):114-26. [6] Niu M, et al. Chem Biol Interact. 2015, 237:66-72. [7] Shrivastava S, et al. Apoptosis. 2014, 19(7):1148-64. + 展開

参考

+ 展開

化学情報

分子量	317.34	化学式	C₁₇H₁₉NO₅
CAS No.	20069-09-4	SDF	Download Piperlongumine SDFをダウンロードする
Smiles	COC1=CC(=CC(=C1OC)OC)C=CC(=O)N2CCC=CC2=O
保管	3年-20°C粉	溶液の保管冷凍と解凍の繰り返しを避けるため小分けにしてください	1年-80°Cin solvent
保管	3年-20°C粉	溶液の保管冷凍と解凍の繰り返しを避けるため小分けにしてください	1个月-20°Cin solvent

In vitro
Batch:

DMSO : 63 mg/mL ( (198.52 mM)；吸湿したDMSOは溶解度を減少させます。新しいDMSOをご使用ください。)

Ethanol : 63 mg/mL

Water : Insoluble

モル濃度計算器

in vivo
Batch:

Add solvents to the product individually and in order.

投与溶液組成計算機

実験計算

モル濃度計算器

質量	濃度	体積	分子量
=	×	×

希釈計算器分子量計算器

投与溶液組成計算機(クリア溶液)

ステップ１：実験データを入力してください。（実験操作によるロスを考慮し、動物数を1匹分多くして計算・調製することを推奨します）

投与量 mg/kg 動物平均体重 g 投与体積（動物毎）μL 動物数匹

ステップ２：投与溶媒の組成を入力してください。（ロット毎に適した溶解組成が異なる場合があります。詳細については弊社までお問い合わせください）

% DMSO + % + % Tween 80 + % ddH₂O

%DMSO+ %

計算結果：

投与溶媒濃度： mg/ml;

DMSOストック溶液調製方法： mg 試薬を μL DMSOに溶解する（濃度 mg/mL, 注：濃度が当該ロットのDMSO溶解度を超える場合はご連絡ください。 )

投与溶媒調製方法：Take μL DMSOストック溶液に μL PEG300，を加え、完全溶解後μL Tween 80，を加えて完全溶解させた後 μL ddH₂O，を加え完全に溶解させます。

投与溶媒調製方法：μL DMSOストック溶液に μL Corn oil，を加え、完全溶解。

注意：１.ストック溶液に沈殿、混濁などがないことをご確認ください；
２.順番通りに溶剤を加えてください。次のステップに進む前に溶液に沈殿、混濁などがないことを確認してから加えてください。ボルテックス、ソニケーション、水浴加熱など物理的な方法で溶解を早めることは可能です。

技術サポート

ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

Handling Instructions

他に質問がある場合は、お気軽にお問い合わせください。

* 必須

* 大学・企業名 大学・企業名を記入してください

* 名前 名前を記入してください

* 電子メール 電子メール・アドレスを記入してください 有効なメールアドレスを入力してください

電話番号

* 内容 お問い合わせ内容をご入力ください

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):